Craft. September 15, 2023 - march 31, 2025. N01DA-22-2253. Task order no. 75N95023F00011 (TO15).
Ended Awarded Last action
- Contract number
- 75N95023F00011
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $799,919
Award facts
- Contract value 100% obligated
- $799,919.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Original award | $799,919 |
About this award
This is a $799,919.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to The Emmes Company LLC, a for-profit limited liability company. The contract supports the NIDA Data, Statistics, and Clinical Trial Support Center and covers a period from September 15, 2023 to March 31, 2025, with a final completion date of April 28, 2025. The contract is not set-aside. Emmes, a global clinical research organization, will provide comprehensive research support services to NIDA, including biostatistical analysis, data management, clinical trial coordination, regulatory support, and operational oversight for complex biomedical research initiatives. Emmes has established itself as a key contractor for multiple NIH institutes, leveraging its expertise in designing, managing, and analyzing clinical trials across various medical and scientific domains.
Quick answers
Who was awarded contract 75N95023F00011?
75N95023F00011 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 15, 2023.
How much is contract 75N95023F00011 worth?
The government has obligated $799,919 on 75N95023F00011.
Is contract 75N95023F00011 an order under another contract?
Yes. 75N95023F00011 is a delivery order under 75N95022D00017, an indefinite delivery contract.
Was contract 75N95023F00011 competed?
The extent of competition for 75N95023F00011 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award